Biology was luminal in 4 cases (40%), human epidermal growth factor receptor (HER) 2 in 1 case (10%), luminal-HER2 in 1 case (10%), and triple-negative breast cancer (TNBC) in 4 cases (40%). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.